Evelyn Hermes-DeSantis, PharmD, BCPS
William Levine Hall, Rm 417C
Phone: (848) 445 6821
PharmD, Ernest Mario School of Pharmacy
Evelyn Hermes-DeSantis, PharmD, BCPS, is a Clinical Professor at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey and is the Director of Drug Information Services at Robert Wood Johnson University Hospital. She received her undergraduate and graduate degrees from Rutgers University. After completing a Specialized Residency in Drug Information Practice at the Medical College of Virginia Hospital in Richmond, Virginia, she practiced at the Drug Information Center at the University of Utah Hospital in Salt Lake City, Utah. Dr. Hermes-DeSantis returned to the East Coast in 1995 to assume a faculty position at Rutgers. She is also a board-certified pharmacotherapy specialist.
Dr. Hermes-DeSantis is the Director of the Drug Information Service at Robert Wood Johnson University Hospital. The Service is an informational resource to healthcare professionals and patients in Robert Wood Johnson University Hospital as well as throughout the State of New Jersey. Dr. Hermes-DeSantis serves on the Pharmacy and Therapeutics Committee at the Robert Wood Johnson University Hospital. The Service writes all of the drug monographs for the Committee’s review. She speaks to many community groups concerning drug interactions and empowering patients to take an active role in their healthcare management.
Scholarly Activities (Research and Publications)
Dr. Hermes-DeSantis’ research focuses in the area of provision of drug information services within in institutions, the relationship between hospital and industrial pharmacy practice, and education of pharmacists.
Barone JA, Hermes DeSantis ER, Adverse drug reactions and drug-induced disorders. In: Herfindal ET, Gourley DR, Eds. Textbook of Therapeutics. Drug and Disease Management. 7th edition. New York: Lippincott, Williams & Wilkins; 2000. P. 21-34
Brunetti L, Hermes-DeSantis ER. The role of colesevelam hydrochloride in hypercholesterolemia and type 2 dibetes mellitus. Annals of Pharmacotherapy 2010;44:1196-1206
Brunetti L, Hermes-DeSantis ER, Stibal DM, Molinelli P. Optimizing the use of hematologic agents: A case-based approach highlighting the use of IVIG, hemin, and azacitidine. US Pharmacist 2010;35(1)(Oncology suppl):4-12
Gore SD, Hermes DeSantis ER. Enhancing survival outcomes in the management of patients with higher-risk myelodysplastic syndromes. Cancer Control 2009;16(Suppl 4):2-10.
Crouch Z, Hermes DeSantis ER. Use of erythropoietin-stimulating agents in breast cancer patients: a risk review. American Journal of Health-System Pharmacy. 2009;66:1180-5
Gore SD, Hermes DeSantis ER. Future directions in myelodysplastic syndrome: Newer agents and the role of combination approaches. Cancer Control 2008;15(Suppl):40-49
Patel S, Hermes DeSantis ER. Treatment of congenital tuberculosis. American Journal of Health-System Pharmacy. 2008;65(21):2026-31
Moore S, Hermes DeSantis ER. Treatment of complications associated with systemic sclerosis. American Journal of Health-System Pharmacists 2008;65(4):315-21
Brunetti L, Hermes DeSantis ER. Treatment of viral myocarditis caused by coxsackievirus B. American Journal of Health-System Pharmacists 2008;65(2):132-7
Sarkar S, Hermes DeSantis ER. Resurgence of colistin use. American Journal of Health-System Pharmacists 2007;64(23):2462-2466
Hermes DeSantis ER, Huang S. Botulinum toxin type A for treatment of refractory gastroparesis American Journal of Health-System Pharmacists 2007;64(21): 2237-2240
Hermes DeSantis ER, Aranda JV. Clinical experience with intravenous ibuprofen lysine in the pharmacologic closure of patent ductus arteriosus. Journal of Pediatric Pharmacology and Therapeutics. 2007;12(3):171-182
Huang S, Hermes DeSantis ER. Treatment of pulmonary arterial hypertension in pregnancy. American Journal of Health-System Pharmacists 2007;64(18): 1922-1926
Hermes-DeSantis ER. Clyman RI. Patent ductus arteriosus: pathophysiology and management. Journal of Perinatology 2006;26:S14-S18
Suh DC, Woodal BS, Shin S, Hermes DeSantis ER. Clinical and economic impact of adverse drug reactions in hospital patients. Annals Pharmacotherapy 2000;34:1373-79
Hermes DeSantis ER, Laumeister BS, Bansal V, Kataria V, Loomba P, Sparkman E. Low molecular weight heparin in the prevention and treatment of thromboembolic disorders. Disease Management and Clinical Outcomes 1998;1(5):166-174
Hermes ER, Hare B. Meperidine neurotoxicity: Three case reports and a review of the literature. Journal of Pharmaceutical Care in Pain and Symptom Control 1993;1(3):5-20
Awards and Honors
Louis P. Jeffrey Award, Eastern States Conference for Pharmacy Residents and Preceptors – 2011